sulfasalazine has been researched along with Helicobacter Infections in 7 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "pylori." | 2.69 | Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease. ( Duncan, HD; Green, JR; Pearce, CB; Timmis, L, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wada, T | 1 |
| Ishimoto, T | 1 |
| Seishima, R | 1 |
| Tsuchihashi, K | 1 |
| Yoshikawa, M | 1 |
| Oshima, H | 1 |
| Oshima, M | 1 |
| Masuko, T | 1 |
| Wright, NA | 1 |
| Furuhashi, S | 1 |
| Hirashima, K | 1 |
| Baba, H | 1 |
| Kitagawa, Y | 1 |
| Saya, H | 1 |
| Nagano, O | 1 |
| Mantzaris, GJ | 1 |
| Archavlis, E | 1 |
| Zografos, C | 1 |
| Zavos, K | 1 |
| Petraki, K | 1 |
| Triadaphyllou, G | 1 |
| Sternon, J | 1 |
| Adler, M | 1 |
| Parente, F | 1 |
| Molteni, P | 1 |
| Bollani, S | 1 |
| Maconi, G | 1 |
| Vago, L | 1 |
| Duca, PG | 1 |
| Rembacken, B | 1 |
| Axon, AT | 1 |
| Bianchi Porro, G | 1 |
| Pearce, CB | 1 |
| Duncan, HD | 1 |
| Timmis, L | 1 |
| Green, JR | 1 |
| Münzová, H | 1 |
| Dítĕ, P | 1 |
| Sevcíková, I | 1 |
| Dolina, J | 1 |
| Novotný, I | 1 |
| Kunovská, M | 1 |
| Taha, AS | 1 |
| Sturrock, RD | 1 |
| Russell, RI | 1 |
1 review available for sulfasalazine and Helicobacter Infections
| Article | Year |
|---|---|
[Digestive and extra-digestive complications of nonsteroidal anti-inflammatory drugs. Preventive and curative strategies].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cyclooxygenase | 1997 |
1 trial available for sulfasalazine and Helicobacter Infections
| Article | Year |
|---|---|
Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Breath Tests; Colitis, Ulcera | 2000 |
5 other studies available for sulfasalazine and Helicobacter Infections
| Article | Year |
|---|---|
Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.
Topics: Adenocarcinoma; Amino Acid Transport System y+; Animals; Biomarkers, Tumor; Cell Transformation, Neo | 2013 |
Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulfasalazine.
Topics: Adult; Aged; Anti-Inflammatory Agents; Colitis, Ulcerative; Helicobacter Infections; Helicobacter py | 1995 |
Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Colitis, Ulcerative; Crohn Disease; Cross-Sectional | 1997 |
[Helicobacter pylori and nonspecific intestinal inflammation].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Colitis, Ul | 2000 |
Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine, and nonsteroidal anti-inflammatory drugs.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Duodenal Ulcer; Female; Gold S | 1992 |